Drugs / GT737
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07676006 | Jul 2026 → Jun 2030 expected | acute myeloid leukemia | Grit Biotechnology | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GT737 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07676006 ↗ |
| Target | CD33 | “Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70” NCT07676006 ↗ |
| Target | CD70 | “Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70” NCT07676006 ↗ |